TY  - JOUR
AU  - Mesia, R
AU  - Iglesias, L
AU  - Lambea, J
AU  - Martínez-Trufero, J
AU  - Soria, A
AU  - Taberna, M
AU  - Trigo, J
AU  - Chaves, M
AU  - García-Castaño, A
AU  - Cruz, J
PY  - 2021
DO  - 10.1007/s12094-020-02533-1
UR  - http://hdl.handle.net/10668/17244
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Head and neck cancers (HNC) are defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence...
LA  - en
KW  - Chemoradiotherapy
KW  - Head and neck cancer
KW  - Human papillomavirus
KW  - Immunotherapy
KW  - Alphapapillomavirus
KW  - Chemoradiotherapy, Adjuvant
KW  - Cisplatin
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - Medical Oncology
KW  - Mouth Neoplasms
KW  - Neoplasm Staging
KW  - Organ Sparing Treatments
KW  - Oropharyngeal Neoplasms
KW  - Radiation-Sensitizing Agents
KW  - Radiotherapy, Adjuvant
KW  - Sentinel Lymph Node Biopsy
KW  - Societies, Medical
KW  - Spain
KW  - Squamous Cell Carcinoma of Head and Neck
TI  - SEOM clinical guidelines for the treatment of head and neck cancer (2020).
TY  - research article
VL  - 23
ER  -